Squarepoint’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-35,425
| Closed | -$106K | – | 2955 |
|
|
2024
Q2 | $106K | Sell |
35,425
-43,588
| -55% | -$131K | ﹤0.01% | 2254 |
|
|
2024
Q1 | $367K | Buy |
79,013
+5,579
| +8% | +$25.9K | ﹤0.01% | 1829 |
|
|
2023
Q4 | $304K | Buy |
73,434
+40,337
| +122% | +$167K | ﹤0.01% | 1951 |
|
|
2023
Q3 | $99.3K | Sell |
33,097
-45,923
| -58% | -$138K | ﹤0.01% | 2251 |
|
|
2023
Q2 | $194K | Buy |
+79,020
| New | +$194K | ﹤0.01% | 2087 |
|
|
2023
Q1 | – | Sell |
-35,281
| Closed | -$123K | – | 2701 |
|
|
2022
Q4 | $123K | Buy |
+35,281
| New | +$123K | ﹤0.01% | 2022 |
|
|
2021
Q1 | – | Sell |
-7,130
| Closed | -$229K | – | 2966 |
|
|
2020
Q4 | $229K | Buy |
+7,130
| New | +$229K | ﹤0.01% | 2052 |
|
|
2020
Q3 | – | Sell |
-8,106
| Closed | -$363K | – | 2625 |
|
|
2020
Q2 | $363K | Buy |
+8,106
| New | +$363K | 0.01% | 1458 |
|
|
2020
Q1 | – | Sell |
-8,918
| Closed | -$348K | – | 2344 |
|
|
2019
Q4 | $348K | Buy |
+8,918
| New | +$348K | ﹤0.01% | 1903 |
|